Blackstone unearths Uniquity Bio with $300M to explore Merck drug's I&I potential
Blackstone unearths Uniquity Bio with $300M to explore Merck drug's I&I potential mbayer Wed, 05/15/2024 - 10:10
16 мая 2024 года
Blackstone unearths Uniquity Bio with $300M to explore Merck drug's I&I potential mbayer Wed, 05/15/2024 - 10:10
Vaxxinity leaders detail retreat from 'abusive relationship' after 3 years on public market aarmstrong Wed, 05/15/2024 - 08:57
Bolt Bio halves workforce and swaps out CEO, while Tenaya lays off 5th of staff jwaldron Wed, 05/15/2024 - 06:52
BioMarin sheds 170 jobs in wake of narrowed R&D refocus jwaldron Wed, 05/15/2024 - 05:34
ACCC to integrate Flatiron clinical trial tech into cancer center network hfloersh Tue, 05/14/2024 - 16:30
Radyus and Dt&CRO partner to bring more South Korean biotechs to the US hfloersh Tue, 05/14/2024 - 13:33
Avenzo, BioAge-backer Sands Capital raises new $555M life sciences fund mbayer Tue, 05/14/2024 - 10:01
Novo Nordisk's Hemlibra rival hits goals in phase 3, teeing up blockbuster showdown with Roche ntaylor Tue, 05/14/2024 - 09:18
Pregnant and lactating trial participants pose little legal risk to sponsors: report hfloersh Mon, 05/13/2024 - 20:11
ASGCT: Why biopharma must face up to the ethical issues around prenatal gene therapies hfloersh Mon, 05/13/2024 - 17:36